← Evidence map

TrialPharmacoEconomics1994

Economic analysis of lenograstim in the correction of neutropenia following chemotherapy for non-Hodgkin's lymphoma.

E Souêtre et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

this paperpooled ittrialcites it

Economic analysis of lenograstim in the correction of neutropenia following chemotherapy for non-Hodgkin's lymphoma. | OpenQuestion